Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease.
about
Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity and osteoporosisAn interaction between the interleukin-6 -174G>C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetesRelationship between Interleukin-6 gene polymorphism and hippocampal volume in antipsychotic-naïve schizophrenia: evidence for differential susceptibility?Modifying effect of a common polymorphism in the interleukin-6 promoter on the relationship between long-term exposure to traffic-related particulate matter and heart rate variability.Anti-inflammatory effect of peroxisome proliferator-activated receptor-γ (PPAR-γ) on non-obese diabetic mice with Sjogren's syndromeGenes and Sjögren's syndrome.Cytokine gene polymorphism in human disease: on-line databases, supplement 2.Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer.Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales' diseaseInterleukin-6 plasmatic levels in patients with head trauma and intracerebral hemorrhage.Horizons in Sjögren's syndrome genetics.Innate immunity SNPs are associated with risk for severe sepsis after burn injury.Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndromeSignificance of Interleukin-6/STAT Pathway for the Gene Expression of REG Iα, a New Autoantigen in Sjögren's Syndrome Patients, in Salivary Duct Epithelial Cells.Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings.Association between IL-6 -174 G/C, IL-6 -634 G/C, and IFN-γ +874 A/T polymorphisms and susceptibility to recurrent pregnancy loss: a meta-analysisInterleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditionsPrimary Sjögren's syndrome: current and emergent aetiopathogenic concepts.Interleukin-6 -634 C/G and -174 G/C polymorphisms in Korean patients undergoing hemodialysis.Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis.Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinomaCirculating interleukin-6 and rheumatoid arthritis: A Mendelian randomization meta-analysis.Proposed mechanisms for cancer- and treatment-related cognitive changesPrognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor).Cytokines in Sjögren's syndrome.Immuno-modulatory gene polymorphisms and outcome in breast and ovarian cancer.Primary Sjogren's syndrome: too dry and too tired.Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T Cells.Preliminary evidence of an association between an interleukin 6 promoter polymorphism and self-reported attentional function in oncology patients and their family caregivers.Genetic susceptibility to periodontitis.The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction.Genetic Associations of Interleukin-related Genes with Graves' Ophthalmopathy: a Systematic Review and Meta-analysisThe effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.Present and future of biologic drugs in primary Sjögren's syndrome.CD38 and interleukin 6 gene polymorphism in egyptians with diffuse large B-cell lymphoma (DLBCL).Innate immunity genes influence the severity of acute appendicitis.Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia.Increased incidence of Sjogren's syndrome in systemic sclerosis: A nationwide population study.Role of the promoter polymorphism IL-6 -174G/C in dermatomyositis and systemic lupus erythematosus.
P2860
Q21283795-91B4CAE0-BFE5-4A62-84FD-90C053C13688Q24803174-AEB758FC-C12C-4A71-9EB6-03D4B6194093Q33560201-E154037B-10EB-4BF7-9DA2-014983DBEB53Q34061785-21AF9BD1-8297-4499-8D07-296EEE61EA6EQ34121408-873FB4F0-39D3-4C30-971A-77086814C6AFQ34363380-8FDF7F6A-5EF4-43CC-AE0A-03166EF0AB07Q34810493-534E7039-6820-42B7-AC60-F353076E1CD6Q35007044-499F828B-718C-46D3-88B7-CA809D03E0AAQ35410782-390B61B7-3975-4D90-852A-2C58602D4AA8Q35412740-A2A3325A-0EC7-4CA9-A3D2-AE861C47B494Q35570872-A664293E-A1CC-4FC3-B674-AC40DB422E9BQ35575098-A0A3EFDF-FA67-482B-9F39-2E1B6B3BF419Q35840812-4A59A17B-216A-4A19-B08D-D3A7B6EBAD18Q36060629-4ACFE9E4-5EF0-4433-90FE-A7C4C71CE02BQ36101133-B1B91C9D-C093-4E97-9FBA-5CF74ABB88ACQ36127770-3B6D52BB-3AD6-4FE5-8D0E-FF61E11482E4Q36161896-1302760B-50E5-4C7A-8BC5-DBBE625542EDQ36163155-EC052522-0952-49EF-B0F1-E3978D07C65FQ36237976-DB72D693-6AC9-4509-BF08-35C9E7C52E5AQ36641560-1B03A605-965A-4118-931F-D13F64491D27Q36925486-72C41DF0-109D-443D-98B2-3173EC0A45F4Q37003697-3C5F5C23-97DC-4FAD-B5C0-2B630C35B913Q37279700-AF84BD46-DFCB-48F4-A190-E1EC1DD155C9Q37339903-39ABA0D3-E8E1-47C4-8F4A-396726A3F738Q37387713-E1538929-1E5C-4F8F-AF3C-7A0E349380AFQ37610477-ED1D1930-7363-4256-A8B8-EE6E3FF661D9Q37690497-C7AC02FC-728A-4D85-9F64-A9A7BEBBA109Q37722551-69AF6A87-51D5-4001-80EF-0401E589BAADQ37730169-26E3B0DA-7BCF-4215-ACA5-84D8C448F7ADQ37963581-AD76F6D6-FE56-42EE-B05D-5F1695BE3FA4Q38355697-BD949BCD-819D-4DC1-9E0A-05BA68F09C5EQ38615348-893BC34D-8583-466E-B5A8-A8F6A0BE0106Q38636465-4A9ADA21-B6A4-4B8C-BF24-42AD53187539Q38648460-E290AAB6-DD38-422B-BF02-C79CC39A9C74Q38822415-DA89A4BC-1AEE-49CB-9449-52AAC8AB6421Q39506851-1E939A9D-B92D-4720-AB62-2C1E9438E74BQ39690673-23871E2D-FED9-45CB-983F-91BD7BFFDACFQ41535503-9AAAA9F0-A302-4681-9421-E409F5C63AF0Q41734803-0B903B8E-2497-4021-9922-1E76C30FA392Q42181793-0D2B7C5C-259A-4BD3-83E5-D7497E04AC7F
P2860
Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Elevated interleukin-6 plasma ...... manifestations of the disease.
@en
Elevated interleukin-6 plasma ...... manifestations of the disease.
@nl
type
label
Elevated interleukin-6 plasma ...... manifestations of the disease.
@en
Elevated interleukin-6 plasma ...... manifestations of the disease.
@nl
prefLabel
Elevated interleukin-6 plasma ...... manifestations of the disease.
@en
Elevated interleukin-6 plasma ...... manifestations of the disease.
@nl
P2093
P356
P1433
P1476
Elevated interleukin-6 plasma ...... manifestations of the disease.
@en
P2093
Hulkkonen J
Pasternack A
Pertovaara M
P304
P356
10.1093/RHEUMATOLOGY/40.6.656
P577
2001-06-01T00:00:00Z